13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-07-29 Event — SEC 0001213900-26-082794 →

Knight Therapeutics Inc. → 60 DEGREES PHARMACEUTICALS, INC. SXTPW

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100
  • Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 1.00
1,107 shares short · +0.5% vs prior

Other 13D/G Filings on 60 DEGREES PHARMACEUTICALS, INC.

FiledFormFilerStakeShares
2026-08-05 SCHEDULE 13G Lind Global Fund III LP — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →